Transgenic mice for conditional gene manipulation in astroglial cells.

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Astrocytes perform crucial brain functions, but studying them in vivo is challenging due to limited manipulation tools.
• Understanding astrocyte roles is vital for comprehending brain function and disease pathogenesis.

Purpose of the Study:

• To develop novel transgenic mouse lines for conditional gene ablation specifically in astrocytes.
• To enable in vivo investigation of astrocyte functions and their involvement in neurological conditions.

Main Methods:

• Generation of transgenic mouse lines utilizing the tamoxifen-inducible CreER(T2)/loxP system and bacterial artificial chromosome (BAC) technology.
• CreER(T2) expression driven by astrocyte-specific promoters (Glast/Slc1a3, Cx30/Gjb6, ApoE, Aqp4).
• Tamoxifen (TAM) injection to induce Cre-mediated recombination in target cells.

Main Results:

• Successful inducible gene ablation in astrocytes across the brain, with regional targeting efficiencies ranging from 20-90%.
• The Glast-driven line also targeted retinal Müller cells and adult neural stem/progenitor cells.
• Inducible recombination observed in specific peripheral organs, and at lower levels in CNS areas with ApoE and Aqp4 promoters.

Conclusions:

• The developed transgenic mouse lines provide powerful tools for conditional astrocyte manipulation in vivo.
• These models will advance research into astrocyte functions in normal brain physiology and in pathological states like aging, disease, and injury.